Indrayani Biotech Ltd

BSE :526445 NSE :- Sector : Diversi..
24.98
Change: -0.38(-1.50%)
52 week Low
21.80
52 week High
77.23
Day low
24.01
Day high
25.89
Prev Close
25.36
Open
24.01
6M return
-48.36%
1Y return
-65.05%
MCap(Rs. in Cr.)
115.48
Total Volume
2,21,754
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Indrayani Biotec
24.98
Change: -0.38 (-1.50%)
1 Year return
-65.05%
Risk (Std Dev)
0.15%
PE Ratio
14.83041
MCap( in Cr.)
115.48
Empire Inds.
1,040.75
Change: 26.40 (2.60%)
1 Year return
0.18%
Risk (Std Dev)
0.13%
PE Ratio
14.28
MCap( in Cr.)
608.61
Thacker & Co.
1,498.00
Change: 59.80 (4.16%)
1 Year return
130.46%
Risk (Std Dev)
0.24%
PE Ratio
7.37955
MCap( in Cr.)
156.44
Bombay Cycle
1,865.80
Change: -34.15 (-1.80%)
1 Year return
7.80%
Risk (Std Dev)
0.10%
PE Ratio
26.38453
MCap( in Cr.)
76.00
Ecoboard Inds.
34.32
Change: -1.80 (-4.98%)
1 Year return
17.21%
Risk (Std Dev)
0.17%
PE Ratio
NM
MCap( in Cr.)
61.19
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Indrayani Biotech to discuss results

Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live News<....

11 Feb 2025 10:32

Indrayani Biotech consolidated net profit declines 77.98% in the September 2024 quarter

Net profit of Indrayani Biotech declined 77.98% to Rs 1.22 crore in the quarter ended September 2024 as against Rs 5.54 crore during the previous quar....

15 Nov 2024 17:59

Indrayani Biotech to table results

Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News</....

11 Nov 2024 17:34

Indrayani Biotech reports consolidated net profit of Rs 0.85 crore in the June 2024 quarter

Net profit of Indrayani Biotech reported to Rs 0.85 crore in the quarter ended June 2024 as against net loss of Rs 0.45 crore during the previous quar....

16 Aug 2024 07:35

Indrayani Biotech announces board meeting date

Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live News</b....

12 Aug 2024 14:32

Indrayani Biotech consolidated net profit rises 258.33% in the March 2024 quarter

Net profit of Indrayani Biotech rose 258.33% to Rs 3.87 crore in the quarter ended March 2024 as against Rs 1.08 crore during the previous quarter end....

31 May 2024 13:45

View More
Subscribe for our
newsletter
Open Account Now